Significant difference in Cmax of Reference drug product [Study As­sess­ment]

posted by Mehul Patel – India, 2021-08-17 10:00 (38 d 01:15 ago) – Posting: # 22520
Views: 633

Hi,

Can anybody please tell what may be the probable reasons behind significant (more than 20%) difference in mean Cmax concentration of Reference product of a same batch number in two different studies conducted at same CRO and on the similar kind of population but different sample size?

Is it correct to compare and expect Reference product's behavior same for all repeated studies?

Moreover, Can 6 months old (frozen) samples yield significant different results as compared to freshly analyzed study samples?

Complete thread:

Activity
 Admin contact
21,693 posts in 4,535 threads, 1,541 registered users;
online 10 (1 registered, 9 guests [including 3 identified bots]).
Forum time: Friday 11:16 CEST (Europe/Vienna)

Tortured data will confess to anything.    Fredric Menger

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5